Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Sep 11, 2017 5:24pm

161 Views

Post# 26681989

RE:RE:RE:RE:RE:RE:RE:RE:Long-Lasting Antitumor Memory ...

LAZERR00 wrote:
In the above mentioned which would be about the best case scenario, 600 m like whaaa, that would bring the stock to 3 dollars if math is correct

More than that imo in short turn after JV,,,, when it comes,, which could be soon... will give instant cred, multipliers will kick in eventually based on projected revenue down the road, then speculation of future applications of laser and indications.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages